To get the syringe units for a target dose: (target dose in mg) (concentration in mg/mL) 100 = units on a U-100 insulin syringe
Organ Protection and Systemic Stability : In systemic toxicity and organ injury research, BPC-157 has been observed to protect the liver, pancreas, and kidneys from induced damage
Standard Beginner Dosage Typical daily dose: 250500 mcg per day Frequency: Split into two doses per day (e.g., 250 mcg AM / 250 mcg PM) for more stable blood levels Cycle length: Most users follow a 26 week cycle , depending on injury severity and response Maintenance dosing (optional): 250 mcg once daily, 23 times per week for ongoing joint support or injury prevention Daily subcutaneous injections of BPC-157 have been shown to significantly improve tissue healing in both acute and chronic injury models. Sikiric et al., Journal of Physiology and Pharmacology Injection Method Route: Subcutaneous (subQ) injection is most common
Enebo LA, Berthelsen KK, Kankam M, et al
WADA does not list DSIP by name on its prohibited substances list as of 2026
Trends in peptide drug discovery